![Russell Beyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell P.
Beyer is currently the Chief Financial Officer at SAB Sciences, Inc. He previously held the same position at SAB Biotherapeutics, Inc. from 2021 to 2023.
Prior to that, he was the Chief Financial Officer at Big Cypress Acquisition Corp.
Mr. Beyer received an undergraduate degree from St. Lawrence University and an MBA from the University of Rochester Simon Business School.
| Unternehmen | Position | Beginn |
|---|---|---|
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Finanzdirektor/CFO | 01.09.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 27.10.2023 |
| BIG CYPR | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rochester Simon Business School
 University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Health Technology |
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
